O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Return
13.05%
This Quarter Return
+15.9%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.71B
AUM Growth
+$1.28B
(+24%)
Cap. Flow
+$755M
Cap. Flow
% of AUM
11.26%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
137
New
19
Increased
49
Reduced
25
Closed
20
Top Buys
| 1 |
RLYP
RELYPSA INC COM
RLYP
|
$249M |
| 2 |
Perrigo
PRGO
|
$119M |
| 3 |
AbbVie
ABBV
|
$107M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$83.9M |
| 5 |
CELG
Celgene Corp
CELG
|
$76.1M |
Top Sells
| 1 |
Merck
MRK
|
$177M |
| 2 |
Elevance Health
ELV
|
$71.8M |
| 3 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
$56.2M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$56.1M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$50.4M |
Sector Composition
| 1 | Healthcare | 84.81% |
| 2 | Financials | 1.2% |
| 3 | Technology | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
76
DELISTED
Sinovac Biotech, Ltd
SVA
| $10M | 0.15% |
1,637,500
-246,700
| -13% | -$1.51M |
|
77
Zoetis
ZTS
$68B
| $9.12M | 0.13% |
+279,000
| New | +$9.12M |
|
78
DaVita
DVA
$9.7B
| $9.06M | 0.13% |
143,000
+13,000
| +10% | +$824K |
|
|
GEVA
79
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $8.41M | 0.12% |
130,000
| – | – |
|
80
InspireMD
NSPR
$102M
| $8.35M | 0.12% |
1
| – | – |
|
|
FRX
81
DELISTED
FOREST LABORATORIES INC
FRX
| $8.34M | 0.12% |
139,000
+19,000
| +16% | +$1.14M |
|
|
VCRA
82
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.99M | 0.1% |
447,500
| – | – |
|
83
Xencor
XNCR
$598M
| $6.42M | 0.09% |
+702,600
| New | +$6.42M |
|
84
United Therapeutics
UTHR
$17.3B
| $6.22M | 0.09% |
+55,000
| New | +$6.22M |
|
|
CBST
85
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $6.2M | 0.09% |
90,000
-814,200
| -90% | -$56.1M |
|
86
MiMedx Group
MDXG
$1.05B
| $6.12M | 0.09% |
+700,000
| New | +$6.12M |
|
|
PTX
87
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $5.85M | 0.09% |
232,080
| – | – |
|
88
Curis
CRIS
$21.1M
| $5.5M | 0.08% |
19,501
| – | – |
|
|
CVD
89
DELISTED
COVANCE INC.
CVD
| $5.2M | 0.08% |
59,000
+11,000
| +23% | +$969K |
|
90
Bio-Techne
TECH
$8.23B
| $4.73M | 0.07% |
200,000
-864,000
| -81% | -$20.5M |
|
91
Fate Therapeutics
FATE
$114M
| $4.41M | 0.06% |
+702,000
| New | +$4.41M |
|
92
Supernus Pharmaceuticals
SUPN
$2.54B
| $4.37M | 0.06% |
580,000
-59,400
| -9% | -$448K |
|
|
QCOR
93
DELISTED
QUESTCOR PHARMA INC
QCOR
| $4.36M | 0.06% |
80,000
| – | – |
|
|
UPI
94
DELISTED
UROPLASTY INC-NEW
UPI
| $3.94M | 0.06% |
1,443,500
| – | – |
|
95
Catalyst Pharmaceutical
CPRX
$2.42B
| $3.7M | 0.05% |
1,895,000
| – | – |
|
|
HSP
96
DELISTED
HOSPIRA INC
HSP
| $3.51M | 0.05% |
+85,000
| New | +$3.51M |
|
97
Acadia Pharmaceuticals
ACAD
$4.3B
| $3.37M | 0.05% |
135,000
-177,000
| -57% | -$4.42M |
|
|
BLRX
98
BioLineRX
BLRX
$15.2M
| $3.19M | 0.05% |
1,892
-333
| -15% | -$561K |
|
|
ANTH
99
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.86M | 0.04% |
116,594
| – | – |
|
|
QLTI
100
DELISTED
QLT Inc
QLTI
| $2.51M | 0.04% |
450,000
-150,000
| -25% | -$836K |
|